Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Healthcare REIT (AHR) Short-Term Debt issuances (2016 - 2025)

American Healthcare REIT (AHR) has disclosed Short-Term Debt issuances for 10 consecutive years, with $33.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short-Term Debt issuances fell 89.64% year-over-year to $33.5 million, compared with a TTM value of $248.5 million through Dec 2025, down 72.12%, and an annual FY2025 reading of $248.5 million, down 72.12% over the prior year.
  • Short-Term Debt issuances was $33.5 million for Q4 2025 at American Healthcare REIT, down from $82.5 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $941.4 million in Q1 2022 and bottomed at $16.6 million in Q1 2021.
  • Average Short-Term Debt issuances over 5 years is $152.9 million, with a median of $95.2 million recorded in 2022.
  • The sharpest move saw Short-Term Debt issuances skyrocketed 5571.08% in 2022, then crashed 89.64% in 2025.
  • Year by year, Short-Term Debt issuances stood at $34.5 million in 2021, then skyrocketed by 166.67% to $92.0 million in 2022, then increased by 8.37% to $99.7 million in 2023, then skyrocketed by 224.47% to $323.5 million in 2024, then plummeted by 89.64% to $33.5 million in 2025.
  • Business Quant data shows Short-Term Debt issuances for AHR at $33.5 million in Q4 2025, $82.5 million in Q3 2025, and $98.5 million in Q2 2025.